Comparative Analysis of Clinical and Pathological Characteristics of Breast Cancer among Premenopausal and Postmenopausal Women
Breast Cancer among Premenopausal and Postmenopausal Women
DOI:
https://doi.org/10.54393/pjhs.v6i5.2915Keywords:
Breast Cancer, Premenopausal, Postmenopausal, Clinical CharacteristicsAbstract
Breast cancer shows distinct clinical and pathological characteristics between premenopausal and postmenopausal women, potentially affecting disease progression and treatment outcomes. Understanding these differences is essential for optimizing management strategies. Objectives: To compare the clinical and pathological characteristics of breast cancer among premenopausal and postmenopausal women. Methods: This retrospective study was conducted at the Department of Histopathology, Quaid-e-Azam Medical College, Bahawalpur, from January to December 2024. A total of 188 breast cancer patients (94 premenopausal, 94 postmenopausal) were included. Clinical variables such as age at diagnosis, family history, tumor laterality, clinical stage, lymph node involvement, and metastasis were analyzed, along with pathological features like histological type, tumor grade, molecular subtype, and hormone receptor status. Data were analyzed using a t-test and a chi-square test. Results: The mean age at diagnosis was significantly lower in premenopausal women (46.96 ± 5.29 years) compared to postmenopausal women (65.87 ± 10.82 years) (p<0.001). A positive family history was more common among premenopausal patients (37.2% vs. 23.4%, p=0.039). Lymph node involvement was higher in premenopausal women (73.4% vs. 59.6%, p=0.045). Tumor laterality, clinical stage, metastasis, histological type, tumor grade, molecular subtype, and hormone receptor status were similar between groups (p>0.05). Conclusions: It was concluded that premenopausal women presented at a younger age, with more frequent family history and lymph node involvement, suggesting a potentially aggressive disease course. However, pathological tumor characteristics were comparable. Early detection and genetic risk assessment are crucial, particularly in younger women.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021 May; 71(3): 209-49. doi: 10.3322/caac.21660.
Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M et al. Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040. The Breast. 2022 Dec; 66: 15-23. doi: 10.1016/j.breast.2022.08.010.
Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global Burden and Trends in Premenopausal and Postmenopausal Breast Cancer: A Population-Based Study. The Lancet Global Health. 2020 Aug; 8(8): e1027-37. doi: 10.1016/S2214-109X(20)30215-1.
Kim HJ, Kim S, Freedman RA, Partridge AH. The Impact of Young Age at Diagnosis (Age<40 Years) on Prognosis Varies by Breast Cancer Subtype: A US SEER Database Analysis. The Breast. 2022 Feb; 61: 77-83. doi: 10.1016/j.breast.2021.12.006.
Kumar R, Abreu C, Toi M, Saini S, Casimiro S, Arora A et al. Onco-biology and Treatment of Breast Cancer in Young Women. Cancer and Metastasis Reviews. 2022 Sep; 41(3): 749-70. doi: 10.1007/s10555-022-10034-6.
Tin Tin S, Reeves GK, Key TJ. Endogenous Hormones and Risk of Invasive Breast Cancer in Pre-and Post-Menopausal Women: Findings from the UK Biobank. British Journal of Cancer. 2021 Jul; 125(1): 126-34. doi: 10.1038/s41416-021-01392-z.
Erdogdu IH, Orenay-Boyacioglu S, Boyacioglu O, Gurel D, Akdeniz N, Meteoglu I. Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases. Journal of Personalized Medicine. 2024 Apr 20; 14(4): 434. doi: 10.3390/jpm14040434.
Osório F, Barros AS, Peleteiro B, Barradas AR, Urbano J, Fougo JL et al. Frailty-Independent Under-Treatment Negative Impact On Survival in Older Patients with Breast Cancer. Journal of Breast Cancer. 2021 Oct; 24(6): 542. doi: 10.4048/jbc.2021.24.e45.
Nimbalkar VP, Rajarajan S, VP S, Alexander A, Kaluve R, Selvam S et al. A Comparative Analysis of Clinicopathological Features and Survival Between Pre- and Postmenopausal Breast Cancer from an Indian Cohort. Scientific Reports. 2023 Mar; 13(1): 3938. doi: 10.1038/s41598-023-30912-5.
Paluch-Shimon S, Cardoso F, Partridge AH, Abulkhair O, Azim HA, Bianchi-Micheli G et al. ESO–ESMO Fifth International Consensus Guidelines for Breast Cancer in Young Women (BCY5). Annals of Oncology. 2022 Nov; 33(11): 1097-118. doi: 10.1016/j.annonc.2022.07.007.
Weiser R, Polychronopoulou E, Kuo YF, Haque W, Hatch SS, Tyler DS et al. De-Escalation of Endocrine Therapy in Early Hormone Receptor-Positive Breast Cancer: When Is Local Treatment Enough? Annals of Surgery. 2021 Oct; 274(4): 654-63. doi: 10.1097/SLA.0000000000005064.
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians. 2023 Jan; 73(1): 17-48. doi: 10.3322/caac.21763.
Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang CC et al. Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database. Clinical Breast Cancer. 2022 Jan; 22(1): 49-59. doi: 10.1016/j.clbc.2021.07.005.
Kocaöz S, Korukluoğlu B, Parlak Ö, Doğan HT, Erdoğan F. Comparison of Clinicopathological Features and Treatments Between Pre-and Postmenopausal Female Breast Cancer Patients–A Retrospective Study. Menopause Review/Przegląd Menopauzalny. 2019 Jun; 18(2): 68-73. doi: 10.5114/pm.2019.85786.
Dodiyi-Manuel A, Ogba ME, Ogba A, Green IA, Musa SI, Adu BG. Comparison of Risk Factors and Clinicopathological Features Between Pre- and Post-Menopausal Patients with Breast Cancer. Nigerian Medical Journal. 2024; 65(6): 1008-15. doi: 10.60787/nmj.v65i6.548.
Bosompem K, Yorke J, Buckman TA, Brenu SG, Nyantakyi M, Aitpillah FS et al. Comparative Analysis of Breast Cancer Characteristics in Young Premenopausal and Postmenopausal Women in Ghana. Scientific Reports. 2024 Feb; 14(1): 2704. doi: 10.1038/s41598-024-52129-w.
Ishaque N and Asad M. Clinicopathological Characteristics of Breast Carcinoma in Premenopausal Women. Journal of Islamabad Medical and Dental College. 2019 Dec; 8(4): 193-7. doi: 10.35787/jimdc.v8i4.476.
Hwang TS, Jeong AR, Na JW, Kim YY, Lee JH, Chung YS et al. A Comparative Study of the Clinical Characteristics of Breast Cancer Patients Less Than 35 Years Old and Older Patients. Korean Journal of Clinical Oncology. 2018 Jun; 14(1): 1-7. doi: 10.14216/kjco.18001.
Ntirenganya F, Twagirumukiza JD, Bucyibaruta G, Rugwizangoga B, Rulisa S. Premenopausal Breast Cancer Risk Factors and Associations with Molecular Subtypes: A Case‐Control Study. International Journal of Breast Cancer. 2021; 2021(1): 5560559. doi: 10.1155/2021/5560559.
Surakasula A, Nagarjunapu GC, Raghavaiah K. A Comparative Study of Pre-and Post-Menopausal Breast Cancer: Risk Factors, Presentation, Characteristics and Management. Journal of Research in Pharmacy Practice. 2014 Jan; 3(1): 12-8. doi: 10.4103/2279-042X.132704.
Uomori T, Horimoto Y, Arakawa A, Iijima K, Saito M. Breast Cancer in Lean Postmenopausal Women Might Have Specific Pathological Features. In Vivo. 2019 Mar; 33(2): 483-7. doi: 10.21873/invivo.11499.
Katsika L, Boureka E, Kalogiannidis I, Tsakiridis I, Tirodimos I, Lallas K et al. Screening for Breast Cancer: A Comparative Review of Guidelines. Life. 2024 Jun; 14(6): 777. doi: 10.3390/life14060777.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments